Nonclinical Safety and Toxicology

Ensuring a drug’s safety profile begins long before it reaches patients. Nonclinical Safety and Toxicology forms the essential foundation that connects discovery with regulatory confidence and clinical readiness. This session focuses on the integrated design of safety assessment programs that combine traditional toxicology with innovative predictive models to detect risks early and reduce late-stage failures. Participants will learn how mechanistic toxicology, safety pharmacology, and regulatory testing converge to identify potential organ toxicities, genotoxic risks, and immunologic responses. The discussions cover both small molecules and advanced modalities, such as biologics, RNA-based therapies, and cell/gene products, where new approaches are redefining toxicology standards.

The session emphasizes predictive and translational strategies—linking in vitro assays, in silico models, and in vivo findings to construct a comprehensive safety profile. Scientists will explore microphysiological systems, organ-on-chip models, and omics-based biomarkers that provide mechanistic insight and improve extrapolation to human outcomes. Case studies will illustrate how these modern tools complement regulatory toxicology requirements, helping to align preclinical data with clinical endpoints. Beyond hazard detection, participants will learn how to contextualize findings using exposure–response relationships and quantitative risk assessment, a critical step for setting safe starting doses and managing therapeutic margins.

This track also delves into the ethical and scientific imperatives of the 3Rs—replacement, reduction, and refinement—promoting smarter study design that maintains scientific integrity while minimizing animal use. Attendees will gain practical guidance on protocol optimization, statistical design, and data interpretation that improve reproducibility and audit readiness. For professionals seeking global engagement through a Pharma Conference, this session provides exposure to emerging guidelines and inspection trends across the US, EU, and Asia-Pacific. Emphasis on predictive toxicology ensures participants understand how computational modeling, machine learning, and integrated data platforms are revolutionizing safety testing and regulatory decision-making.

By combining classical toxicology principles with next-generation technologies, this session offers a roadmap for building safety into innovation. It’s ideal for nonclinical scientists, regulatory experts, and project leaders who must ensure that every candidate entering clinical development does so with a transparent, evidence-based understanding of risk.